滥用甲基胺的男性中功能障碍反处理:来自神经生理学和计算方法的证据
Sadegh Ghaderi1, Jamal Amani Rad1, Mohammad Hemami1
1Institute for Cognitive and Brain Sciences, Shahid Beheshti University, Tehran, Iran.
Neuropsychologia
|March 9, 2024
概括
甲基胺使用障碍 (MUD) 损害了反处理,对最佳选择和负面反的敏感性降低. 神经分析显示,MUDs中较低的前额 teta 功率,影响行为调整.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 计算精神病学是一种计算精神病学.
背景情况:
- 甲基胺使用障碍 (MUD) 是一个重大的公共卫生挑战,与神经反处理中断有关.
- 虽然在物质依赖中研究了反处理,但其在MUD中的具体机制仍然不清楚,特别是在学习速度和探索-开发权衡方面.
- 在MUD中认知组件和神经支之间的相互作用需要进一步调查.
研究的目的:
- 与健康对照人群相比,研究MUD患者反处理的神经认知机制.
- 在概率学习任务中评估行为学习参数和相关的神经活动.
- 探索认知缺陷和MUD中神经改变之间的关系.
主要方法:
- 运用了一个概率学习任务,涉及奖励和惩罚.
- 采用基于Q学习范式的数学建模来分析行为数据.
- 测量脑电图 (EEG) 来评估神经活动,重点关注 teta 功率和其他强化学习标记.
主要成果:
- 数学建模表明,MUD患者对最佳选择的敏感性降低,对负面反的学习能力降低.
- 脑电图数据显示,在负反处理过程中,MUDs中的中端前端乙太功率较低.
- 与强化学习相关的关键EEG测量,包括与反相关的消极性和P300,是完整的,但在MUD中,价值灵敏度和中端前端活动之间的联系被切断了.
结论:
- 在MUD中功能失调的反处理可能源于甲基胺对皮层-层多巴胺电路的影响,影响前带皮层功能.
- 这些发现突出了MUDs的特定神经认知缺陷,特别是在区分最佳选择和从负面结果中学习方面.
- 了解这些机制可以帮助开发针对MUD的有针对性的治疗干预措施.
相关概念视频
Attention-Deficit/Hyperactivity Disorder
67
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
67
Drug Abuse and Addiction: Pharmacological Phenomena
472
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
472


